The bidding phase for the initial public offering (IPO) of Medi Assist Healthcare Services Ltd concluded on Wednesday, with the book build issue witnessing over 16 times subscription against the original offer during the three-day bidding period from January 15 to January 17, 2024. With the T+3 listing rule in effect, investors are now eagerly anticipating the finalization of share allotment, expected today.
Investors who applied for the Medi Assist IPO are advised to stay vigilant for the announcement of the Medi Assist IPO allotment. Following the allotment, investors can check their status online through the BSE or the official registrar’s website, Link Intime Private Limited.
For convenience, investors can log in directly to the BSE link at bseindia.com/investors/appli_check.aspx or the Link Intime portal at linkintime.co.in/mipo/ipoallotment.html to check the Medi Assist IPO allotment status.
**To check Medi Assist IPO allotment status online on BSE:**
1. Log in at the direct BSE link: bseindia.com/investors/appli_check.aspx.
2. Select Medi Assist Healthcare Services Limited IPO.
3. Enter the Medi Assist Healthcare Services IPO application number.
4. Enter your PAN details.
5. Click on ‘I’m not a robot’.
6. Click on the ‘Submit’ button.
Your Medi Assist Healthcare Services IPO allotment status will be displayed on the computer or smartphone screen.
**To check Medi Assist IPO allotment status online on Link Intime:**
1. Log in at the direct Link Intime web link: linkintime.co.in/MIPO/Ipoallotment.html.
2. Select Medi Assist Healthcare Services Limited IPO.
3. Enter your PAN details.
4. Click on the ‘Search’ option.
Your Medi Assist Healthcare Services IPO allotment status will soon become available on the computer or smartphone screen.
**Medi Assist IPO Grey Market Premium (GMP) Today:**
Market observers report that shares of Medi Assist Healthcare Services Limited are trading at a premium of ₹25 in the grey market today. This suggests an anticipation that the Medi Assist IPO listing price would be around ₹443 (₹418 + ₹25), approximately 6% higher than its price band of ₹397 to ₹418 per equity share. Investors are advised to monitor the market closely for further developments.
